PT Diastika Biotekindo Tbk (IDX:CHEK)
Indonesia · Delayed Price · Currency is IDR 98.00
-2.00 (-2.00%)
At close: Oct 30, 2026
IDX:CHEK Revenue
PT Diastika Biotekindo Tbk had revenue of 73.11B IDR in the quarter ending September 30, 2026, with 36.84% growth. This brings the company's total for the last twelve months to 224.95B, up 30.83% year-over-year. In the year 2025, PT Diastika Biotekindo Tbk had annual revenue of 201.31B with 30.05% growth. That makes PT Diastika Biotekindo Tbk the 36,364th largest company in the world by revenue and 636th in Indonesia.
Revenue (ttm)
224.95B
Revenue Growth
+30.83%
P/S Ratio
1.76
Revenue / Employee
1.83B
Employees
123
Market Cap
395.27B
Revenue by Segment
- Clinical Diagnostics 141.86B 70.5%
- Life Science 59.45B 29.5%
Fiscal year ended Dec 31, 2025 See the full IDX:CHEK breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 201.31B | 46.51B | 30.05% |
| Dec 31, 2024 | 154.79B | 25.69B | 19.90% |
| Dec 31, 2023 | 129.10B | 11.63B | 9.90% |
| Dec 31, 2022 | 117.47B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.